InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,826.59
(
0.05%
)
Post# of 174
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

PennyWorld

Send PM Follow Ignore
Followers 75
Posts 9161
Boards Moderated 0
Alias Born 04/25/2002

PennyWorld

Member Level

Re: None

Friday, 06/24/2022 6:10:29 AM

Friday, June 24, 2022 6:10:29 AM

Post# of 174
So, this is encouraging......

Acer Therapeutics has hit a regulatory speed bump on its quest to advance a taste-masked alternative to existing urea cycle disorder (UCD) meds like Buphenyl. Still, the company and its production partner should be able to sort things out “relatively quickly,” Acer’s chief executive said.

https://www.fiercepharma.com/manufacturing/fda-rebuffs-acer-and-reliefs-urea-cycle-disorder-prospect-over-pending-contract
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up